点滴装置市場：コンタクトポジション別、エンドユーザー別-2025-2030年の世界予測

点滴装置市場の2023年の市場規模は125億4,000万米ドルで、2024年には132億4,000万米ドルに達すると予測され、CAGR 6.05％で成長し、2030年には189億3,000万米ドルに達すると予測されています。

静脈内投与（IV）機器市場には、薬物や水分を血流に直接投与するために設計されたさまざまな製品が含まれます。これには、静脈カテーテル、輸液ポンプ、投与セット、関連アクセサリーなどが含まれます。IV機器の必要性は、主に病院やヘルスケア施設において、迅速かつ正確な投与や水分補給、栄養投与、化学療法の実施など、重要な役割を果たすことから生じています。エンドユーザーには、病院、クリニック、外来診療センターが主に含まれ、自己投与や在宅治療の増加傾向を背景に在宅医療サービスも増えています。

輸液機器の市場成長は、がんや糖尿病などの慢性疾患の有病率の上昇、世界人口の急速な高齢化、在宅医療サービスの拡大による影響が大きいです。輸液システムの技術的進歩や、スマートでワイヤレス制御の輸液機器への動きは、市場プレーヤーに大きなビジネスチャンスをもたらします。こうした機会を生かすため、市場参入企業は、患者の快適性と安全性を高めるスマートヘルスケア技術・機器に焦点を当てた研究開発への投資を検討すべきです。

しかし、厳しい規制政策、高度な機器に伴う高コスト、不適切な使用に伴う感染症や合併症のリスクなどの要因により、市場拡大には限界があります。このような課題から、機器の安全性と効率性を継続的に改善するとともに、リスクを軽減するためのヘルスケア専門家向けトレーニングプログラムが必要となります。

イノベーションのためには、企業は環境に優しくコスト効率の高い素材の開発や、AIやIoTを活用してリアルタイムのモニタリングやデータ分析機能を提供するインテリジェント輸液システムの開発を模索すべきです。これらの進歩を統合することで、患者ケアの転帰と業務効率の向上につながります。全体として、市場はダイナミックであり、技術的な改善と高度なヘルスケアソリューションに対する需要の増加に迅速に対応しており、継続的な進化の態勢を整えている有望な市場であるが競合情勢であることを示しています。

市場力学：急速に進化する点滴装置市場の主要市場インサイトを公開

点滴装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患の流行
  • 疾病の早期診断・治療への傾斜
  • 在宅ヘルスケアへの傾向の高まり
• 市場抑制要因
  • 高コストと厳しい規制
• 市場機会
  • 点滴装置の進歩と改善
  • 遠隔医療プラットフォームの新たな動向
• 市場の課題
  • 熟練した専門家の不足と製品の安全性への懸念

ポーターの5つの力：点滴装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：点滴装置市場における外部からの影響の把握

外部マクロ環境要因は、点滴装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析点滴装置市場における競合情勢の把握

点滴装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス点滴装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、点滴装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨点滴装置市場における成功への道筋を描く

点滴装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患の罹患率が増加
    • 病気の早期診断と治療への傾向
    • 在宅ヘルスケアへの傾向の高まり
  • 抑制要因
    • 高コストと厳しい規制枠組み
  • 機会
    • 点滴装置の進歩と改善
    • 遠隔医療プラットフォームの新たなトレンド
  • 課題
    • 熟練した専門家の不足と製品の安全性に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 点滴装置市場連絡先ポジション別

• 管理セット
  • 血液投与セット
  • ソリューション管理セット
• ドリップチャンバー
• 輸液ポンプ
• IVカテーテル
• ニードルレスコネクタ
• 固定装置
• ストップコックとチェックバルブ

第7章 点滴装置市場：エンドユーザー別

• 外来診療センター
• ホームケア
• 病院・クリニック

第8章 南北アメリカの点滴装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の点滴装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの点滴装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam Inc.
• Advin Health Care
• Angel Electronic Equipment Co., Ltd.
• Argon Medical Devices, Inc.
• B. Braun SE
• Baxter International, Inc.
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• CODAN ARGUS AG
• Cook Group Incorporated
• Freudenberg Medical, LLC
• Henry Schein, Inc.
• ICU Medical, Inc
• Ivenix Inc.
• Merck KGaA
• Novo Nordisk A/S
• Pfizer Inc.
• QIAGEN
• Siemens AG
• Smith & Nephew PLC
• Stryker Corporation
• Teleflex Incorporated.
• Terumo Corporation
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. INTRAVENOUS EQUIPMENT MARKET RESEARCH PROCESS
• FIGURE 2. INTRAVENOUS EQUIPMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. INTRAVENOUS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. INTRAVENOUS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRAVENOUS EQUIPMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTRAVENOUS EQUIPMENT MARKET DYNAMICS
• TABLE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY BLOOD ADMINISTRATION SETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SOLUTION ADMINISTRATION SETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY IV CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NEEDLELESS CONNECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SECUREMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STOPCOCKS & CHECK VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. CANADA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 34. CANADA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 51. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 54. INDIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. ITALY INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 106. ITALY INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. POLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 118. POLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. QATAR INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 121. QATAR INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM INTRAVENOUS EQUIPMENT MARKET SIZE, BY CONTACT POSITION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM INTRAVENOUS EQUIPMENT MARKET SIZE, BY ADMINISTRATION SETS, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. INTRAVENOUS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. INTRAVENOUS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Intravenous Equipment Market was valued at USD 12.54 billion in 2023, expected to reach USD 13.24 billion in 2024, and is projected to grow at a CAGR of 6.05%, to USD 18.93 billion by 2030.

The market for intravenous (IV) equipment involves a diverse range of products designed for the administration of medications and fluids directly into the bloodstream. This includes items such as IV catheters, infusion pumps, administration sets, and related accessories. The necessity of IV equipment arises mainly from its critical role in hospitals and healthcare facilities, where it facilitates rapid and accurate dosing and hydration, administration of nutrients, and delivery of chemotherapy, among other applications. End-users predominantly include hospitals, clinics, and outpatient care centers, and increasingly home healthcare services driven by the growing trend of self-administration and home treatment.

Market growth for IV equipment is largely influenced by the rising prevalence of chronic diseases such as cancer and diabetes, a rapidly aging global population, and the expansion of home healthcare services. Technological advancements in infusion systems and the movement towards smart, wireless-controlled IV equipment present significant opportunities for market players. To capitalize on these opportunities, market entrants should consider investing in R&D focused on smart healthcare technologies and devices that enhance patient comfort and safety.

However, market expansion faces limitations due to factors such as stringent regulatory policies, high costs associated with advanced equipment, and the risk of infections and complications associated with improper use. These challenges necessitate continuous improvements in device safety and efficiency, along with training programs for healthcare professionals to mitigate risks.

For innovation, companies should explore developing eco-friendly, cost-effective materials and leveraging AI and IoT for intelligent infusion systems that provide real-time monitoring and data analytics capabilities. Integrating these advances can lead to enhanced patient care outcomes and operational efficiencies. Overall, the market is dynamic, responding rapidly to technological improvements and increased demand for advanced healthcare solutions, indicating a promising but competitive landscape poised for continuous evolution.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Equipment Market

The Intravenous Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases worldwide
  • Inclination toward early diagnosis and treatment of diseases
  • Growing trend towards home healthcare
• Market Restraints
  • High cost and stringent regulatory framework
• Market Opportunities
  • Advancements and improvements in intravenous equipment
  • Emerging trend of telemedicine platforms
• Market Challenges
  • Limited skilled professionals and product safety concerns

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Equipment Market

A detailed market share analysis in the Intravenous Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Equipment Market

A strategic analysis of the Intravenous Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Equipment Market, highlighting leading vendors and their innovative profiles. These include Abcam Inc., Advin Health Care, Angel Electronic Equipment Co., Ltd., Argon Medical Devices, Inc., B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CODAN ARGUS AG, Cook Group Incorporated, Freudenberg Medical, LLC, Henry Schein, Inc., ICU Medical, Inc, Ivenix Inc., Merck KGaA, Novo Nordisk A/S, Pfizer Inc., QIAGEN, Siemens AG, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated., Terumo Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Intravenous Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Contact Position, market is studied across Administration Sets, Drip Chambers, Infusion Pumps, IV Catheters, Needleless Connectors, Securement Devices, and Stopcocks & Check Valves. The Administration Sets is further studied across Blood Administration Sets and Solution Administration Sets.
• Based on End User, market is studied across Ambulatory Care Centers, Home Care, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases worldwide
    • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
    • 5.1.1.3. Growing trend towards home healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and stringent regulatory framework
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and improvements in intravenous equipment
    • 5.1.3.2. Emerging trend of telemedicine platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Limited skilled professionals and product safety concerns
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Intravenous Equipment Market, by Contact Position

• 6.1. Introduction
• 6.2. Administration Sets
  • 6.2.1. Blood Administration Sets
  • 6.2.2. Solution Administration Sets
• 6.3. Drip Chambers
• 6.4. Infusion Pumps
• 6.5. IV Catheters
• 6.6. Needleless Connectors
• 6.7. Securement Devices
• 6.8. Stopcocks & Check Valves

7. Intravenous Equipment Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Care Centers
• 7.3. Home Care
• 7.4. Hospitals & Clinics

8. Americas Intravenous Equipment Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Intravenous Equipment Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Equipment Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam Inc.
• 2. Advin Health Care
• 3. Angel Electronic Equipment Co., Ltd.
• 4. Argon Medical Devices, Inc.
• 5. B. Braun SE
• 6. Baxter International, Inc.
• 7. Becton, Dickinson and Company
• 8. Boston Scientific Corporation
• 9. Cardinal Health, Inc.
• 10. CODAN ARGUS AG
• 11. Cook Group Incorporated
• 12. Freudenberg Medical, LLC
• 13. Henry Schein, Inc.
• 14. ICU Medical, Inc
• 15. Ivenix Inc.
• 16. Merck KGaA
• 17. Novo Nordisk A/S
• 18. Pfizer Inc.
• 19. QIAGEN
• 20. Siemens AG
• 21. Smith & Nephew PLC
• 22. Stryker Corporation
• 23. Teleflex Incorporated.
• 24. Terumo Corporation
• 25. Thermo Fisher Scientific Inc.